Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study
Kidney transplantation; Office blood pressure; Home blood pressure; Sodium; Potassium
Abstract :
[en] Background
In kidney transplant (Kt) recipients, hypertension is a major risk for cardiovascular complications but also for graft failure. Blood pressure (BP) control is therefore mandatory. Office BP (OBP) remains frequently used for clinical decisions, however home BP (HBP) have brought a significant improvement in the BP control. Sodium is a modifiable risk factor, many studies accounted for a decrease of BP with a sodium restricted diet. Increased potassium intake has been also recommended in hypertension management. Using an agreement between office and home BP, the present study investigated the relations between the BP control in Kt recipients and their urinary excretion and dietary consumption of sodium and potassium.
Methods
The BP control defined by OBP <140/90 mmHg and HBP <135/85 mmHg was tested in 70 Kt recipients (mean age 56 +/- 11.5 years; mean graft survival 7 +/- 6.6 years) treated with antihypertensive medications. OBP and HBP were measured with a validated oscillometric device (Omron M6(R)). The 24-hour urinary sodium (Na+) and potassium (K+) excretions as well as dietary intakes were compared between controlled and uncontrolled (in office and at home) recipients. Non parametric Wilcoxon Mann--Whitney Test was used for between groups comparisons and Fisher's exact test for frequencies comparisons. Pearson correlation coefficients and paired t-test were used when sample size was >30.
Results
Using an agreement between OBP and HBP, we identified controlled (21%) and uncontrolled recipients (49%). Major confounding effects susceptible to interfere with the BP regulation did not differ between groups, the amounts of sodium excretion were similar (154 +/- 93 vs 162 +/- 88 mmol/24 h) but uncontrolled patients excreted less potassium (68 +/- 14 vs 54 +/- 20 mmol/24 h; P = 0.029) and had significantly lower potassium intakes (3279 +/- 753 vs 2208 +/- 720 mg/24 h; P = 0.009), associated with a higher urinary Na+/K + ratio. Systolic HBP was inversely and significantly correlated to urinary potassium (r = -0.48; P = 0.002), a positive but non significant relation was observed with urinary sodium (r = 0,30;P = 0.074).
Conclusions
Half of the treated hypertensive Kt recipients remained uncontrolled in office and at home. Restoring a well-balanced sodium/potassium ratio intakes could be a non pharmacological opportunity to improve blood pressure control.
Disciplines :
Urology & nephrology
Author, co-author :
Saint-Remy, Annie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie
SOMJA, Mélanie ; Centre Hospitalier Universitaire de Liège - CHU > Secteur diététique
Gellner, Karen; Krankenhaus Düren-Medizinische Klinik II - Düren - Germany
WEEKERS, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie
BONVOISIN, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie
Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie
Language :
English
Title :
Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study
for the Transplant Therapy Outcomes Study Group. Study 1: long-term cardiovascular risk after kidney transplantation. First M, Transplant Rev 2003 4 47
Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Campistol J, Romero R, Paul J, Guttiérrez-Dalmau A, Nephrol Dial Transplant 2004 19 suppl 3 62 66
Association of chronic kidney graft failure with recipient blood pressure. Opelz G, Wujciak T, Ritz E, Kidney Int 1998 53 217 222 10.1046/j.1523-1755.1998.00744.x 9453022 (Pubitemid 28066925)
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R, Hypertension 2006 47 846 853 10.1161/01.HYP. 0000215363.69793.bb 16567588 (Pubitemid 44297554)
Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Agena F, Dos Santos Prado E, Soarez Souza P, Da Silva GV, Lemos FB, Mion D Jr, Nahas WC, David-Neto E, Nephrol Dial Transplant 2011 26 3745 3749 10.1093/ndt/gfr143 21441398
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G, Circulation 2005 111 1777 1783 10.1161/01.CIR.0000160923.04524.5B 15809377 (Pubitemid 40525142)
Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Stergiou GS, Bliziotis IA, Am J Hypertens 2011 24 123 134 10.1038/ajh.2010.194 20940712
Burnier M, Bochud M, Schmieder R, Dietary sodium intake and hypertension. European Society of Hypertension Scientific Newsletter 2009 10: n°40
Nutrition in cardiovascular disease: salt in hypertension and heart failure. He F, Burnier M, MacGregor, Eur Heart J 2011 32 3073 3080 10.1093/eurheartj/ehr194 21705359
World Health Organization, Prevention of Cardiovascular Disease: Guidelines for assessment and management of cardiovascular risk World Health Organization, Geneva 2007
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ, JAMA 1997 277 20 1624 1632 10.1001/jama.1997.03540440058033 9168293 (Pubitemid 27231195)
ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension Practice Guidelines for home blood pressure monitoring. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G, J Hum Hypertens 2010 24 779 785 10.1038/jhh.2010.54 20520631
NUBEL-Table belge de composition des aliments, (Bruxelles, juin 2009, 5e edition) and with the NUBEL database www.nubel.com)
Institut Paul Lambin, Table de composition des aliments 1200 Bruxelles 2004
Souci S, Fachmann W, Krout H, La composition des aliments, tableaux des valeurs nutritives Medpharm, Stuggart 5e 1994
World Health Organization, Diet, nutrition and the prevention of chronic disease. Report of a Joint WHO/FAO Expert Consultation WHO, Geneva 2003 technical report n°916
Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Opelz G, Döhler B, Am J Transplant 2005 5 2725 2731 10.1111/j.1600-6143.2005.01093.x 16212633
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. Appel L, Moore T, Obarzanek E, Vollmer W, Svetkey L, Sacks F, Bray G, Vogt T, Cutler J, Windhauser M, Lin P, Karanja N, N Engl J Med 1997 336 1117 1124 10.1056/NEJM199704173361601 9099655 (Pubitemid 27374693)
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. He F, MacGregor G, J Hum Hypertens 2002 16 761 770 10.1038/sj.jhh.1001459 12444537 (Pubitemid 36007929)
Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Agena F, Prado Edos S, Souza PS, da Silva GV, Lemos FB, Mion D Jr, Nahas WC, David-Neto E, Nephrol Dial Transplant 2011 26 11 3745 3749 10.1093/ndt/gfr143 21441398
Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? Covic A, Segall L, Goldsmith D, Transplantation 2003 76 11 1640 1642 10.1097/01.TP.0000091288. 19441.E2 14702541 (Pubitemid 37549843)
A prospective study of the physician effect on blood pressure in renal-transplant recipients. Prasad G, Nash M, Zaltzman J, Nephrol Dial Transplant 2003 18 996 1000 10.1093/ndt/gfg038 12686677 (Pubitemid 36592545)
Hypertension in cyclosporine-treated renal transplant recipients is sodium-dependent. Curtis J, Luke R, Jones P, Dietheim A, Am J Med 1988 85 134 138 10.1016/S0002-9343(88)80331-0 3041828
Incidence and long-term cost of steroid-related side effects after renal transplantation. Veenstra D, Best J, Hornberger J, Sullivan SD, Hricik DE, Am J Kidney Dis 1999 33 829 839 10.1016/S0272-6386(99)70414-2 10213637 (Pubitemid 29214678)
Salt intakes around the world: implications for public health. Brown I, Tzoulaki I, Elliott P, Int J Epidemiol 2009 38 791 813 10.1093/ije/dyp139 19351697
Urinary potassium is as reliable as urinary nitrogen for use as a recovery biomarker in dietary studies of free living individuals. Tasevska N, Runswick S, Bingham S, J Nutr 2006 136 1334 1340 16614426
U.S. Department of Health and Human Services US Department of Agriculture. Sodium and Potassium, Dietary Guidelines for Americans 2005. Chapter 8. 6th Edition. U.S. Department of Health and Human Services and U.S. Department of Agriculture U.S. Government Printing Office, Washington, DC 2005 www.health.gov/dietaryguidelines/dga2005/document/pdf/Chapter8.pdf
CARI. The CARI guidelines Nutritional management of hypertension in adult kidney transplant recipients. Chadban S, Chan M, Fry K, Patwardhan A, Ryan C, Trevillian P, Westgarth F, Nephrology 2010 15 56 S61 20591046
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. He F, MacGregor G, J Hum Hypertens 2009 23 363 384 10.1038/jhh.2008.144 19110538
fatal and nonfatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion. Stolar-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff, et al. JAMA 2011 305 17 1777 1785 10.1001/jama.2011.574 21540421
Ritz E, Salt and hypertension. Nephrology 2010 15 49 52
Dietary sodium: the dark horse amongst cardiovascular and renal risk factors. Mimran A, du Cailar G, Nephrol Dial Transplant 2008 23 2138 2141 10.1093/ndt/gfn160 18456679 (Pubitemid 351957628)
Renal determinants of the salt-sensitivity of blood pressure. Chioléro A, Würzner G, Burnier M, Nephrol Dial Transplant 2001 16 452 458 10.1093/ndt/16.3.452 11239015 (Pubitemid 32229273)
Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. Geleijnse JM, Kok FJ, Grobbee DE, J Hum Hypertens 2003 17 471 480 10.1038/sj.jhh.1001575 12821954 (Pubitemid 36903334)
Role of potassium in regulating blood flow and blood pressure. Haddy F, Vanhoutte P, Feletou M, Am J Physiol Regul Integr Comp Physiol 2006 290 546 R552 16467502
Sodium and potassium in the pathogenesis of hypertension. Adrogué H, Madias N, N Engl J Med 2007 356 1966 1978 10.1056/NEJMra064486 17494929 (Pubitemid 46740306)
Salt intake and hypertension in renal transplant patients. Moeller T, Buhl M, Schorr U, Distler A, Sharma AM, Clin Nephrol 2000 53 3 159 163 10749292 (Pubitemid 30141324)
Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. Prasad G, Huang M, Nash M, Zaltzman, Transpl Proc 2005 37 1896 1897 10.1016/j.transproceed.2005.04.002 (Pubitemid 40790861)
The role of dietary cations in the blood pressure of renal transplant recipients. Prasad G, Huang M, Nash M, Zaltzman, Clin Transplant 2006 20 1 37 42 10.1111/j.1399-0012.2005.00437.x 16556151 (Pubitemid 43349022)
The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients. Keven K, Yalçin S, Canbakan S, Kutlay S, Sengül S, Erturk S, Erbay B, Transplant Proc 2006 38 1323 1326 10.1016/j.transproceed.2006.02.103 16797292
Sodium intake and blood pressure in renal transplant recipients. Van den Berg E, Geleijnse J, Brink E, Van Baak M, Homan Van Der Heide J, Gans R, Navis G, Bakker S, Nephrol Dial Transplant 2012 27 8 3352 3359 10.1093/ndt/gfs069 22499024
Sodium intake, ACE inhibition, and progression to ESRD. Vegter S, Perna A, Postma M, Navis G, Remuzzi G, Ruggenenti P, J Am Soc Nephrol 2012 23 165 173 10.1681/ASN.2011040430 22135311
Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease. Cook N, Obarzanek E, Cutler J, Buring J, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK, Arch Intern Med 2009 169 1 32 40 10.1001/archinternmed.2008.523 19139321
Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients? Leiba A, Vald A, Peleg E, Shamiss A, Grossmann E, Nutrition 2005 21 4 462 466 10.1016/j.nut.2004.08.021 15811766 (Pubitemid 40462466)